Connie L. Matsui
Independent Chair of the BoardMs. Connie L. Matsui M.B.A. has been Independent Chairman of the Board at Sutro Biopharma, Inc. since June 24, 2019. She general management experience in the biotechnology industry. She served as Director at Halozyme, Inc until 2025. Ms. Matsui served as an Executive Vice President of Corporate Strategy and Communication at Biogen Inc. (also known as, Biogen Idec Inc.) since November 2003. Ms. Matsui served in various leadership positions at Biogen Idec, Inc since 2004 until 2009. She served in various leadership positions at IDEC Pharmaceutical. Ms. Matsui retired from Biogen Idec in January 2009 as Executive Vice President, Knowledge and Innovation Networks. She serves as Independent Chairperson and Director at Artelo Biosciences, Inc. since May 2, 2017. Ms. Matsui has extensive general management experience in the biotechnology industry. Ms. Matsui served as Senior Vice President, Planning and Resource Development at Biogen Inc. from September 2000 to November 2003. She joined Idec Pharmaceuticals Corp. in November 1992 as Senior Director, Planning and Resource Development with primary responsibility for strategic planning and human resources. Ms. Matsui served as Vice President of overseeing Investor Relations, corporate communications, human resources, project management and strategic planning at Idec Pharmaceuticals Corp. in December 1994 and to Senior Vice President, Planning and Resource Development in September 2000. Among the major roles she held after joining IDEC in November 1992 were: Senior Vice President, overseeing investor relations, corporate communications, human resources, project management and strategic planning. Ms. Matsui served as Collaboration Chair for the late stage development and commercialization of rituximab (tradenames: Rituxan® and MabThera®) in Partnership with Roche and Genentech and Project Leader for Zevalin®, the first radioimmunotherapy approved by the U.S. FDA. From 1977 to 1991, Ms. Matsui served in a variety of marketing and general management positions at Wells Fargo Bank including Vice President responsible for Consumer Retirement Programs and Vice President in charge of companywide Employee Relations and Communications. She has been the Independent Chairperson of the Board at Artelo Biosciences, Inc. since May 2, 2017. She served as Independent Chairman of Halozyme Therapeutics, Inc. and was its Independent Director since July 31, 2006 until May 02, 2025. She serves as a Member of the Advisory Council at Stanford Graduate School of Business. She has been active on a number of not-for-profit boards and served as National President/Board Chair of the Girl Scouts of the USA from 1999 to 2002. Ms. Matsui received her B.A. and M.B.A. both from Stanford University.
Positions
- Company NameSutro Biopharma, Inc.Stock CodeSTROPositionIndependent Chair of the BoardColleagues
- JCJane ChungCEO & Director
- CLConnie L. MatsuiIndependent Chair of the Board
- GKGregory K. ChowChief Financial Officer
- HGHans-Peter GerberChief Scientific Officer
- JRJames R. SwartzFounder
- DLDevendra LuharSenior Vice President of Technical Operations
- JMJoseph M. LobackiIndependent Director
- JPJames P. PanekIndependent Director
- CVCarlos V. PayaChair of the Scientific Advisory Board
- Company NameArtelo Biosciences, Inc.Stock CodeARTLPositionIndependent Chairperson of the BoardColleagues
- GDGregory D. GorgasPresident, CEO, Secretary & Director
- MEMark E. SpringCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- AYAndrew YatesSenior VP & Chief Scientific Officer
- SDSteven D. ReichChief Medical Officer
- JHJason H. BaybuttSenior Vice President of Finance
- SKSteven KellyIndependent Director
- DWDouglas W. BlayneyIndependent Director
- TATamara A. FavoritoIndependent Director
